by Lauren Amphlett | Oct 8, 2021 | Antifungals in development, General interest, Information and Learning, Latest research news
Many of our patients already know of the increasing need for new antifungal drugs; treatments for fungal diseases like aspergillosis have significant limitations. Toxicities, drug-drug interactions, resistance, and dosing are all issues that can complicate therapy;...
by GAtherton | Jan 20, 2020 | Antifungals in development, Information and Learning, Latest research news
A review published recently describes the new antifungals that are in the pipeline that offer hope for the future. The new drugs described in the review have novel mechanisms of action to overcome resistance, and some offer new formulations providing distinct...